264 related articles for article (PubMed ID: 11135250)
41. Humoral immune response in chronic relapsing experimental allergic encephalomyelitis (r-EAE) in guinea pigs.
Olsson T; Henriksson A; Link H; Kristensson K
Prog Clin Biol Res; 1984; 146():179-86. PubMed ID: 6201888
[No Abstract] [Full Text] [Related]
42. Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
Pepinsky RB; Shao Z; Ji B; Wang Q; Meng G; Walus L; Lee X; Hu Y; Graff C; Garber E; Meier W; Mi S
J Pharmacol Exp Ther; 2011 Nov; 339(2):519-29. PubMed ID: 21807883
[TBL] [Abstract][Full Text] [Related]
43. Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions.
Alvarez JI; Saint-Laurent O; Godschalk A; Terouz S; Briels C; Larouche S; Bourbonnière L; Larochelle C; Prat A
Neurobiol Dis; 2015 Feb; 74():14-24. PubMed ID: 25448765
[TBL] [Abstract][Full Text] [Related]
44. [Intensity of phospholipid and cholesterol synthesis in the brain and spinal cord of rabbits with experimental allergic encephelomyelitis].
Taranova NN; Katsnel'son IP
Biull Eksp Biol Med; 1976 Mar; 81(3):291-3. PubMed ID: 953270
[TBL] [Abstract][Full Text] [Related]
45. [Glycolipids of rabbit spinal cord in experimental allergic encephalomyelitis].
Taranova NP; Katsnelson IP; Belokhvostova AS
Vopr Med Khim; 1975; 21(4):385-90. PubMed ID: 1216759
[TBL] [Abstract][Full Text] [Related]
46. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.
Bennett J; Basivireddy J; Kollar A; Biron KE; Reickmann P; Jefferies WA; McQuaid S
J Neuroimmunol; 2010 Dec; 229(1-2):180-91. PubMed ID: 20832870
[TBL] [Abstract][Full Text] [Related]
47. Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis.
Uchida Y; Sumiya T; Tachikawa M; Yamakawa T; Murata S; Yagi Y; Sato K; Stephan A; Ito K; Ohtsuki S; Couraud PO; Suzuki T; Terasaki T
Mol Neurobiol; 2019 Mar; 56(3):2039-2056. PubMed ID: 29984400
[TBL] [Abstract][Full Text] [Related]
48. A spatial analysis of the blood-brain barrier damage in experimental allergic encephalomyelitis.
Juhler M; Blasberg RG; Fenstermacher JD; Patlak CS; Paulson OB
J Cereb Blood Flow Metab; 1985 Dec; 5(4):545-53. PubMed ID: 3877064
[TBL] [Abstract][Full Text] [Related]
49. Centrally administered pertussis toxin inhibits microglia migration to the spinal cord and prevents dissemination of disease in an EAE mouse model.
Yin JX; Tu JL; Lin HJ; Shi FD; Liu RL; Zhao CB; Coons SW; Kuniyoshi S; Shi J
PLoS One; 2010 Aug; 5(8):e12400. PubMed ID: 20811645
[TBL] [Abstract][Full Text] [Related]
50. Early pathological alterations of lower lumbar cords detected by ultrahigh-field MRI in a mouse multiple sclerosis model.
Mori Y; Murakami M; Arima Y; Zhu D; Terayama Y; Komai Y; Nakatsuji Y; Kamimura D; Yoshioka Y
Int Immunol; 2014 Feb; 26(2):93-101. PubMed ID: 24150245
[TBL] [Abstract][Full Text] [Related]
51. Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Bénardais K; Pul R; Singh V; Skripuletz T; Lee DH; Linker RA; Gudi V; Stangel M
Neurosci Lett; 2013 Oct; 555():165-70. PubMed ID: 24076006
[TBL] [Abstract][Full Text] [Related]
52. Glial fibrillary acidic protein in acute and chronic relapsing experimental allergic encephalomyelitis (EAE).
Smith ME; Somera FP; Swanson K; Eng LF
Prog Clin Biol Res; 1984; 146():139-44. PubMed ID: 6609373
[No Abstract] [Full Text] [Related]
53. Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice.
Wang D; Li SP; Fu JS; Zhang S; Bai L; Guo L
J Neurophysiol; 2016 Nov; 116(5):2173-2179. PubMed ID: 27535376
[TBL] [Abstract][Full Text] [Related]
54. Early detection of liposome brain localization in rat experimental allergic encephalomyelitis.
Rousseau V; Denizot B; Le Jeune JJ; Jallet P
Exp Brain Res; 1999 Apr; 125(3):255-64. PubMed ID: 10229016
[TBL] [Abstract][Full Text] [Related]
55. [Intensity of incorporation of 2-C14-acetate into the cerebrosides and gangliosides of the brain and spinal cord of rabbits in experimental allergic encephalomyelitis].
Taranova NP; Katsnel'son IP
Vopr Med Khim; 1976; 22(1):108-12. PubMed ID: 1025874
[TBL] [Abstract][Full Text] [Related]
56. Differential Expression of Klotho in the Brain and Spinal Cord is Associated with Total Antioxidant Capacity in Mice with Experimental Autoimmune Encephalomyelitis.
Emami Aleagha MS; Harirchian MH; Lavasani S; Javan M; Allameh A
J Mol Neurosci; 2018 Apr; 64(4):543-550. PubMed ID: 29542092
[TBL] [Abstract][Full Text] [Related]
57. Distribution of the blood-brain barrier in heterotopic brain transplants and its relationship to the lesions of EAE.
Knobler RL; Marini JC; Goldowitz D; Lublin FD
J Neuropathol Exp Neurol; 1992 Jan; 51(1):36-9. PubMed ID: 1371310
[TBL] [Abstract][Full Text] [Related]
58. Differential permeability of the BBB in acute EAE: enhanced transport of TNT-alpha.
Pan W; Banks WA; Kennedy MK; Gutierrez EG; Kastin AJ
Am J Physiol; 1996 Oct; 271(4 Pt 1):E636-42. PubMed ID: 8897850
[TBL] [Abstract][Full Text] [Related]
59. Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood-brain barrier.
Kim HN; Kim YR; Ahn SM; Lee SK; Shin HK; Choi BT
J Neurochem; 2015 Nov; 135(3):577-88. PubMed ID: 26285165
[TBL] [Abstract][Full Text] [Related]
60. Mild experimental autoimmune encephalitis as a tool to induce blood-brain barrier dysfunction.
Boettger MK; Weishaupt A; Geis C; Toyka KV; Sommer C
J Neural Transm (Vienna); 2010 Feb; 117(2):165-9. PubMed ID: 19946712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
